FDA Import Refusal 1FX-5544940-9/20002/2 — CIPLA LTD

CIPLA LTD — FEI 3017000295

The FDA refused shipment 1FX-5544940-9/20002/2 from CIPLA LTD (India) on Jul 24, 2026. The refused product falls under Drugs and Biologics — NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Jul 24, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61GDB84 NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.